High Expression of the Pi-Transporter SLC20A1/Pit1 in Calcific Aortic Valve Disease Promotes Mineralization through Regulation of Akt-1

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  El Husseini, Diala ^a   Boulanger, Marie Chloé ^a   Fournier, Dominique ^a   Mahmut, Ablajan ^a   Bossé, Yohan ^a   Pibarot, Philippe ^a   Mathieu, Patrick ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; FOSCARNET; PHOSPHOTRANSFERASE; PROTEIN AKT 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PIT 1; UNCLASSIFIED DRUG;

ADULT; AGED; AORTA VALVE DISEASE; APOPTOSIS; ARTICLE; CALCIFIC AORTIC VALVE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME REGULATION; ENZYME RELEASE; FEMALE; HEART MITOCHONDRION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MINERALIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE; APOPTOSIS; CALCINOSIS; CELLS, CULTURED; CYTOCHROMES C; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MIDDLE AGED; MITOCHONDRIA; PHOSPHATES; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE III;

EID: 84871897290     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053393     Document Type: Article

References (20)

1. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, et al. (1997) Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 29: 630-634.
2. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, et al. (2005) A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 352: 2389-2397.
3. Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, et al. (2008) Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 359: 1343-1356.
4. Chan KL, Teo K, Dumesnil JG, Ni A, Tam J, et al. (2010) Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 121: 306-314.
5. Mathieu P, Despres JP, Pibarot P (2007) The 'valvulo-metabolic' risk in calcific aortic valve disease. Can J Cardiol 23 Suppl B: 32B-39B.
6. Giachelli CM, Jono S, Shioi A, Nishizawa Y, Mori K, et al. (2001) Vascular calcification and inorganic phosphate. Am J Kidney Dis 38: S34-S37.
7. Li X, Yang HY, Giachelli CM, (2006) Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 98: 905-912.
8. Cote N, El Husseini D, Pepin A, Guauque-Olarte S, Ducharme V, et al. (2012) ATP acts as a survival signal and prevents the mineralization of aortic valve. J Mol Cell Cardiol 52: 1191-1202.
9. Proudfoot D, Skepper JN, Hegyi L, Farzaneh-Far A, Shanahan CM, et al. (2001) The role of apoptosis in the initiation of vascular calcification. Z Kardiol 90Suppl 3: 43-46.
10. Loghman-Adham M, (1996) Use of phosphonocarboxylic acids as inhibitors of sodium-phosphate cotransport. Gen Pharmacol 27: 305-312.
11. Matheny RW Jr, Adamo ML, (2009) Current perspectives on Akt Akt-ivation and Akt-ions. Exp Biol Med (Maywood) 234: 1264-1270.
12. Lau WL, Pai A, Moe SM, Giachelli CM, (2011) Direct effects of phosphate on vascular cell function. Adv Chronic Kidney Dis 18: 105-112.
13. Mune S, Shibata M, Hatamura I, Saji F, Okada T, et al. (2009) Mechanism of phosphate-induced calcification in rat aortic tissue culture: possible involvement of Pit-1 and apoptosis. Clin Exp Nephrol 13: 571-577.
14. Giachelli CM, Speer MY, Li X, Rajachar RM, Yang H, (2005) Regulation of vascular calcification: roles of phosphate and osteopontin. Circ Res 96: 717-722.
15. Son BK, Akishita M, Iijima K, Eto M, Ouchi Y, (2008) Mechanism of pi-induced vascular calcification. J Atheroscler Thromb 15: 63-68.
16. Ow YP, Green DR, Hao Z, Mak TW, (2008) Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol 9: 532-542.
17. Pohjolainen V, Mustonen E, Taskinen P, Napankangas J, Leskinen H, et al. (2012) Increased thrombospondin-2 in human fibrosclerotic and stenotic aortic valves. Atherosclerosis 220: 66-71.
18. Villa-Bellosta R, Bogaert YE, Levi M, Sorribas V, (2007) Characterization of phosphate transport in rat vascular smooth muscle cells: implications for vascular calcification. Arterioscler Thromb Vasc Biol 27: 1030-1036.
19. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, et al. (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87: E10-E17.
20. Beck GR Jr, Zerler B, Moran E, (2000) Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci U S A 97: 8352-8357.